Search

Scherlinger, M., and G. C. Tsokos. 2023. “Neurotransmitters Arrive to Control Systemic Autoimmunity”. Cell Metab 35: 728-29.

Scherlinger, M., J. Sibilia, G. C. Tsokos, and J. E. Gottenberg. 2023. “Chronic Stimulation With SARS-CoV-2 Spike Protein Does Not Trigger Autoimmunity”. Clin Immunol 248: 109264.

Tian, J., H. Zhou, D. Fang, P. Yi, P. Cao, J. Liu, F. Xiong, et al. 2022. “The Global Burden of Heterogeneity of Lupus Erythematosus Interventional Trials”. J Autoimmun 128: 102798.

Pan, W., M. Scherlinger, N. Yoshida, M. G. Tsokos, and G. C. Tsokos. 2022. “PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma”. J Immunol 209: 621-28.

Li, H., M. G. Tsokos, and G. C. Tsokos. 2022. “Lymphocytes in the Neighborhood: Good or Bad for the Kidney?”. J Clin Invest 132.

Koga, T., K. Ichinose, and G. C. Tsokos. 2022. “Tissue Resident Cell Processes Determine Organ Damage in Systemic Lupus Erythematosus”. Clin Immunol 234: 108919.

Huang, C., P. Yi, M. Zhu, W. Zhou, B. Zhang, X. Yi, H. Long, et al. 2022. “Safety and Efficacy of Fecal Microbiota Transplantation for Treatment of Systemic Lupus Erythematosus: An EXPLORER Trial”. J Autoimmun 130: 102844.

Huang, C., P. Yi, M. Zhu, W. Zhou, B. Zhang, X. Yi, H. Long, et al. 2022. “Erratum to ‘Safety and Efficacy of Fecal Microbiota Transplantation for Treatment of Systemic Lupus Erythematosus: An EXPLORER Trial’ [J. Autoimmun. 130, June 2022, 102844]”. J Autoimmun 131: 102862.

Hisada, R., N. Yoshida, M. Umeda, C. Burbano, R. Bhargava, M. Scherlinger, M. Kono, V. C. Kyttaris, S. Krishfield, and G. C. Tsokos. 2022. “The Deacetylase SIRT2 Contributes to Autoimmune Disease Pathogenesis by Modulating IL-17A and IL-2 Transcription”. Cell Mol Immunol 19: 738-50.

Tsokos, G. C. 2021. “Criteria, Criteria All Around But Not an Insight into Lupus”. Rheumatology (Oxford) 60: 3037-38.